Latency-Associated Peptide Prevents Skin Fibrosis in Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma

This publication has 30 references indexed in Scilit:

• The Human Hair Follicle: A Reservoir of CD40+ B7-Deficient Langerhans Cells that Repopulate Epidermis After UVB Exposure
  Journal of Investigative Dermatology, 1998
• Expression of connective tissue growth factor in human renal fibrosis
  Kidney International, 1998
• PATHOGENESIS OF SCLERODERMA
  Rheumatic Disease Clinics of North America, 1996
• The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.
  Proceedings of the National Academy of Sciences, 1996
• Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
  Journal of Investigative Dermatology, 1996
• Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.
  Journal of Clinical Investigation, 1990
• The pro domain of pre-pro-transforming growth factor .beta.1 when independently expressed is a functional binding protein for the mature growth factor
  Biochemistry, 1990
• Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
  Nature, 1990
• Chronic graft-versus-host disease (GVHD) as a model for scleroderma
  Cellular Immunology, 1983
• Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
  The Journal of Experimental Medicine, 1978